Drug Profile
Influenza virus DNA vaccine
Latest Information Update: 02 Feb 2007
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals; Influenza virus DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 01 Oct 1998 Preclinical development for Influenza virus infections in USA (IM)